Why insider trading matters?

If management teams do not own any relevant stakes in the companies they guide, they may not be focused on creating wealth for shareholders to the same degree, compared to those that see their personal wealth increase when share prices rise.

- Klaus Gugler, Economist
Tracon Pharmaceuticals, Inc. (TCON)
Sector: Healthcare; Industry: Biotechnology

TRACON Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for cancer and wet age-related macular degeneration (AMD). The company also develops TRC102, a small molecule that is in Phase II clinical trial for mesothelioma, Phase I clinical trial for solid tumors and lung cancer, and Phase I/II clinical trial for solid tumors and lymphomas; and TRC253, a small molecule high affinity competitive inhibitor of wild type androgen receptor (AR) and multiple AR mutant receptors that is in Phase I/II clinical trial for the treatment prostate cancer. The company has license agreements with Ambrx, Inc.; Santen Pharmaceutical Co. Ltd.; Roswell Park Cancer Institute and Health Research Inc.; Case Western Cancer Center; and Lonza Sales AG, as well as a cooperative research and development agreement with National Cancer Institute. TRACON Pharmaceuticals, Inc. was founded in 2004 and is headquartered in San Diego, California.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2020-08-20 THEUER CHARLES President and CEO Buy 30,000 $1.58 $47,400 No
2020-08-18 THEUER CHARLES President and CEO Buy 44,843 $1.63 $73,021 No
2020-08-13 THEUER CHARLES President and CEO Buy 20,000 $1.73 $34,500 No
2020-06-24 THEUER CHARLES President and CEO Buy 9,895 $1.90 $18,800 No
2020-06-15 PELLETIER SAUNDRA L Director Buy 5,500 $2.04 $11,209 Yes
2020-05-22 THEUER CHARLES President and CEO Buy 10,592 $1.90 $20,119 No
2020-03-13 THEUER CHARLES President and CEO Buy 4,100 $1.13 $4,624 No
2020-03-12 THEUER CHARLES President and CEO Buy 20,000 $1.43 $28,639 No
2020-03-10 THEUER CHARLES President and CEO Buy 10,000 $1.87 $18,691 No
2020-01-23 WIGGINS MARK C Chief Business Officer Buy 5,000 $4.02 $20,102 No
2019-12-09 Puissance Cross-Border Opportunities V LLC 10%-Owner Sell 384,130 $2.93 $1,127,379 No
2019-08-09 THEUER CHARLES President and CEO Buy 50,000 $0.45 $22,500 No
2018-12-21 THEUER CHARLES President and CEO Buy 49,000 $0.66 $32,222 No
2018-03-27 Viswanathan Ravi 10%-Owner Buy 707,964 $2.70 $1,911,503 Yes
2018-03-27 Sonsini Peter W. 10%-Owner Buy 707,964 $2.70 $1,911,503 Yes
2018-03-27 SANDELL SCOTT D 10%-Owner Buy 707,964 $2.70 $1,911,503 Yes
2018-03-27 MOTT DAVID M 10%-Owner Buy 707,964 $2.70 $1,911,503 Yes
2018-03-27 KERINS PATRICK J 10%-Owner Buy 707,964 $2.70 $1,911,503 Yes
2018-03-27 Florence Anthony A. Jr. 10%-Owner Buy 707,964 $2.70 $1,911,503 Yes
2018-03-27 BASKETT FOREST 10%-Owner Buy 707,964 $2.70 $1,911,503 Yes
2018-03-27 BARRIS PETER J 10%-Owner Buy 707,964 $2.70 $1,911,503 Yes
2018-03-27 BARRETT M JAMES 10%-Owner Buy 707,964 $2.70 $1,911,503 Yes
2018-03-27 New Enterprise Associates 14, L.P. 10%-Owner Buy 707,964 $2.70 $1,911,503 Yes
2017-06-02 LARUE WILLIAM R Director Sell 2,500 $2.69 $6,732 No
2016-11-29 BARRETT M JAMES 10%-Owner Buy 869,565 $5.75 $4,999,999 No
2016-11-29 BARRIS PETER J 10%-Owner Buy 869,565 $5.75 $4,999,999 No
2016-11-29 BASKETT FOREST 10%-Owner Buy 869,565 $5.75 $4,999,999 No
2016-11-29 Florence Anthony A. Jr. 10%-Owner Buy 869,565 $5.75 $4,999,999 No
2016-11-29 KERINS PATRICK J 10%-Owner Buy 869,565 $5.75 $4,999,999 No
2016-11-29 KOLLURI KRISHNA KITTU 10%-Owner Buy 869,565 $5.75 $4,999,999 No

Insider Smart

SERVICE CORP INTERNATIONAL (SCI) - WALTRIP W BLAIR, Director of $SCI made a buy at 34.65, was he convinced the bottom of the box is a strong support? Well, seems he is not wrong.

Insider Smart

CEDAR FAIR L.P. (FUN) - Another crash victim, Cedar Fair L.P. took a deep dive from $54 to $13, insiders were confidence and eagerly jumped in around $27. With insiders on your side, this would be an easy add and hold to get your cost under $20. Stock is about to breach $40 in the coming weeks.